Common use of Limitations on the Collection, Use and Disclosure of PHI Clause in Contracts

Limitations on the Collection, Use and Disclosure of PHI. If CP intends to Disclose PHI to a Third Party for financial benefit unrelated to Treatment, Payment or Operations (TPO), it must secure patient consent. Patient authorizations for sale of PHI must specifically state that the CP is receiving payment in exchange for PHI and whether the PHI can be further exchanged for payment by the recipient. The CP may not sell or disclose PHI derived from the P3N, except as defined by HIPAA and HITECH. PHI shall be collected, Used and/or Disclosed only to the extent necessary to accomplish specific purposes, in accordance with federal and state law and this Agreement. CP shall be required to comply with federal and state laws governing the Use of PHI for research. Notwithstanding these limitations, CP may retain, use and re-disclose PHI in accordance with Applicable Law, the terms of this Agreement, the terms of the CP-MO Agreement, and the CP’s record retention policies and procedures. If the CP has agreed to more stringent terms with its MOs, those will take precedence.

Limitations on the Collection, Use and Disclosure of PHI. If CP intends to Disclose PHI to a Third Party for financial benefit unrelated to Treatment, Payment or Operations (TPO), it must secure patient consent. Patient authorizations for sale of PHI must specifically state that the CP is receiving payment in exchange for PHI and whether the PHI can be further exchanged for payment by the recipient. The CP may not sell or disclose PHI derived from the P3N, except as defined by HIPAA and HITECH. PHI shall be collected, Used and/or Disclosed only to the extent necessary to accomplish specific purposes, in accordance with federal and state law and this Agreement. CP shall be required to comply with federal and state laws governing the Use of PHI for research. Notwithstanding these limitations, CP may retain, use and re-disclose PHI in accordance with Applicable Law, the terms of this Agreement, the terms of the CP-CP- MO Agreement, and the CP’s record retention policies and procedures. If the CP has agreed to more stringent terms with its MOs, those will take precedence.

Limitations on the Collection, Use and Disclosure of PHI. If CP intends to Disclose PHI to a Third Party for financial benefit unrelated to Treatment, Payment or Health Care Operations (TPO), it must secure patient consent. Patient authorizations for sale of PHI must specifically state that the CP is receiving payment in exchange for PHI and whether the PHI can be further exchanged for payment by the recipient. The CP may not sell or disclose PHI derived from the P3N, except as defined by HIPAA and HITECH. PHI shall be collected, Used and/or Disclosed only to the extent necessary to accomplish specific purposes, in accordance with federal and state law and this Agreement. CP shall be required to comply with federal and state laws governing the Use of PHI for research. Notwithstanding these limitations, CP may retain, use and re-disclose PHI in accordance with Applicable Law, the terms of this Agreement, the terms of the CP-MO Agreement, and the CP’s record retention policies and procedures. If the CP has agreed to more stringent terms with its MOs, those will take precedence.